Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
BMI may serve as prognostic tool for advanced, aggressive breast cancers

BMI may serve as prognostic tool for advanced, aggressive breast cancers

New global study of targeted therapies for breast cancer

New global study of targeted therapies for breast cancer

Docetaxel given after doxorubicin reduces recurrence

Docetaxel given after doxorubicin reduces recurrence

Anthracyclines improve survival in HER2-positive breast cancer patients

Anthracyclines improve survival in HER2-positive breast cancer patients

Targeted therapy and chemotherapy shrinks breast cancer metastases in brain

Targeted therapy and chemotherapy shrinks breast cancer metastases in brain

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

Taxol-type drugs give slight boost to survival rates in early breast cancer

Taxol-type drugs give slight boost to survival rates in early breast cancer

Bristol-Myers Squibb granted NDA for ixabepilone

Bristol-Myers Squibb granted NDA for ixabepilone

Tykerb (lapatinib) - new anti-cancer treatment approved

Tykerb (lapatinib) - new anti-cancer treatment approved

Study indicates heart damage from some cancer drugs worsens over the years

Study indicates heart damage from some cancer drugs worsens over the years

Gene amplification could guide treatment for high-risk breast cancer

Gene amplification could guide treatment for high-risk breast cancer

Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy

Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy

Great news for breast cancer patients

Great news for breast cancer patients

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Launch date announced for Abraxane to treat metastatic breast cancer

Launch date announced for Abraxane to treat metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA acquires Aesgen for $32 million

First patient dosed with Tesmilifene in pivotal breast cancer study

First patient dosed with Tesmilifene in pivotal breast cancer study